20th International Congress » Parkinson's Disease: Clinical Trials II and Non-PD Clinical Trials

Date: Thursday, June 23, 2016

Time: 12:00pm-1:30pm

Session Type: Guided Poster Tour

Meeting: 20th International Congress

12:00pm-1:30pm: A healthy volunteer phase 1 study of RE-024, a potential phosphopantothenate replacement therapy for patients with pantothenate kinase-associated neurodegeneration (PKAN)

R.D. Marshall, A. Harring-Abbott, K. Lucey, K. Leach, M. Beconi, J. Hunt, H. Plotkin (San Diego, CA, USA)

12:00pm-1:30pm: Acute admissions in people with Parkinson’s – More than just frailty

N. Leopold, B. Mohamed, C. Thomas (Cardiff, United Kingdom)

12:00pm-1:30pm: Copper chelation efficacy of alginate/chitosan based D-penicillamine nanoparticles in rat model of non-Wilsonian brain copper toxicosis

A. Pal, B.R. Thapa, R.K. Vasishta, R. Prasad (Chandigarh, India)

12:00pm-1:30pm: Development of a human neuroblastoma model of pantothenate kinase-associated neurodegeneration

A. Di Marco, G. Auciello, A. Vecchi, D. Vignone, M.R. Battista, E. Bracacel, F. Bonelli, E. Nizi, E. Monteagudo, M. Beconi (Pomezia, Italy)

12:00pm-1:30pm: Effect of patient characteristics on motor function in response to 35–50 mg of inhaled levodopa (CVT-301) in patients with Parkinson’s disease: Results from a phase 2b study

P.A. LeWitt, M.I. Freed, M. Leinonen, A. Sedkov, H. Murck (West Bloomfield, MI, USA)

12:00pm-1:30pm: KINECT 3: A randomized, double-blind, placebo-controlled phase 3 trial of valbenazine (NBI-98854) for tardive dyskinesia

S.A. Factor, R.A. Hauser, S. Siegert, G.S. Liang, C.F. O'Brien (Atlanta, GA, USA)

12:00pm-1:30pm: Levodopa, placebo and rotigotine change biomarker levels for oxidative stress

S. Muhlack, M. Kinkel, L. Herrmann, L. Tönges, T. Müller (Bochum, Germany)

12:00pm-1:30pm: Multi-modal recruitment strategy leads to expeditious enrollment in STEADY-PD III

B.L. Greco, T. Simuni, J. Lowell, K.C. Hodgeman, S. Sharma, C.A. Marshall, J. Denmark, W. Galpern, J.L. Goudreau, C. Meuiner, C. Sia, C.A. Thomas, D. Young, K.M. Biglan (Rochester, NY, USA)

12:00pm-1:30pm: Patient experiences following Parkinson’s disease treatment with inhaled levodopa: Results from a Phase 2b study

P. LeWitt, A. Niyazov, A. Sedkov, H. Murck, A. Guo (West Bloomfield, MI, USA)

12:00pm-1:30pm: Transcranial versus root repeated magnetic stimulation as a treatment of psychogenic movement disorders

B. Garcin, C. Hubsch, L. Lliescu, L. Naccache, M. Vidailhet, E. Fournier, F. Mesrati, E. Roze, B. Degos (Paris, France)

« View all sessions from the 20th International Congress.